FHL2 and malignant colon neoplasm: In contrast, co-transection with a control TSB had no effect on the level of FHL2 mRNA expression in colon cancer cells (Fig. 4B), confirming that miR-340-5p specifically targets FHL2 mRNA in HT-29 colon cancer cell line.